Tatva Chintan Pharma Chem Ltd consolidated Q3FY26 profit climbs to Rs. 15.16 crores

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended December 31, 2025.

Financial Results (Q3 FY2026) - QoQ Comparison

The company has reported total income of Rs. 133.068 crores during the period ended December 31, 2025 as compared to Rs. 124.524 crores during the period ended September 30, 2025.

The company has posted net profit / (loss) of Rs. 15.165 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 9.917 crores for the period ended September 30, 2025.

The company has reported EPS of Rs. 6.49 for the period ended December 31, 2025 as compared to Rs. 4.24 for the period ended September 30, 2025.

Financials	Q3 FY2026	Q2 FY2026	% Change
Total Income	₹ 133.068 crs	₹124.524 crs	6.86%
Net Profit	₹15.165 crs	₹9.917 crs	52.92%
EPS	₹6.49	₹4.24	53.07%

Financial Results (Q3 FY2026) - YoY Comparison

The company has reported total income of Rs. 133.068 crores during the period ended December 31, 2025 as compared to Rs.85.940 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.15.165 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.0.138 crores for the period ended December 31, 2024.

The company has reported EPS of Rs.6.49 for the period ended December 31, 2025 as compared to Rs.0.06 for the period ended December 31, 2024.

Financials	Q3 FY2026	Q3 FY2025	% Change
Total Income	₹ 133.068 crs	₹85.940 crs	54.84%
Net Profit	₹15.165 crs	₹0.138 crs	10,889.13%
EPS	₹6.49	₹0.06	10,716.67%

Financial Results (9 Months Ended FY2026) - YoY Comparison

The company has reported total income of Rs.375.611 crores during the 9 Months period ended December 31, 2025 as compared to Rs.276.057 crores during the 9 Months period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.31.733 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.4.683 crores for the 9 Months period ended December 31, 2024.

The company has reported EPS of Rs.13.57 for the 9 Months period ended December 31, 2025 as compared to Rs.2 for the 9 Months period ended December 31, 2024.

Financials	9 Months Ended FY2026	9 Months Ended FY2025	% Change
Total Income	₹375.611 crs	₹276.057 crs	36.06%
Net Profit	₹31.733 crs	₹4.683 crs	577.62%
EPS	₹13.57	₹2	578.50%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 1390.40 as compared to the previous close of Rs. 1371.70. The total number of shares traded during the day was 5461 in over 727 trades.

The stock hit an intraday high of Rs. 1400.00 and intraday low of 1320.00. The net turnover during the day was Rs. 7486429.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q3FY26 Q3FY2026 9MFY26 9MFY2026 ResultUpdate